Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [21] Outcomes of Renal Transplantation in End-Stage Renal Disease Patients with Nonischemic Very Low Ejection Fraction Heart Failure
    Demir, Mehmet Emin
    Merhametsiz, Ozgur
    TURKISH JOURNAL OF NEPHROLOGY, 2021, 30 (01): : 70 - 76
  • [22] Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis
    Pakchotanon, R.
    Gladman, D. D.
    Su, J.
    Urowitz, M. B.
    LUPUS, 2018, 27 (03) : 468 - 474
  • [23] Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD)
    Ejaz, Ayesha
    Junejo, Abdul Manan
    Ali, Muhammad
    Ashfaq, Ahsan
    Hafeez, Abdul Rauf
    Khan, Sadaqat Ali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [24] Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study
    Jeon, Hong Jae
    Bae, Hong Jin
    Ham, Young Rok
    Choi, Dae Eun
    Na, Ki Ryang
    Ahn, Moon-Sang
    Lee, Kang Wook
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (01) : 116 - 123
  • [25] Progression of Osteoporosis After Kidney Transplantation in Patients With End-Stage Renal Disease
    Park, W. Y.
    Han, S.
    Choi, B. S.
    Park, C. W.
    Yang, C. W.
    Kim, Y. -S.
    Kim, J. I.
    Moon, I. S.
    Chung, B. H.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (05) : 1033 - 1037
  • [26] Hydration status of patients with end-stage renal disease after kidney transplantation
    Gueutin, Victor
    Ficheux, Maxence
    Chatelet, Valerie
    Lecouf, Angelique
    Henri, Patrick
    de Ligny, Bruno Hurault
    Ryckelynck, Jean-Philippe
    Lobbedez, Thierry
    CLINICAL TRANSPLANTATION, 2011, 25 (06) : E656 - E663
  • [27] Renal transplantation in systemic lupus erythematosus: Comparison of graft survival with other causes of end-stage renal disease
    Horta-Baas, Gabriel
    Camargo-Coronel, Adolfo
    Guadalupe Miranda-Hernandez, Dafhne
    Gabriela Gonzalez-Parra, Leslie
    del Socorro Romero-Figueroa, Maria
    Perez-Cristobal, Mario
    REUMATOLOGIA CLINICA, 2019, 15 (03): : 140 - 145
  • [28] Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience
    Naranjo-Escobar, J.
    Manzi, E.
    Posada, J. G.
    Mesa, L.
    Echeverri, G. J.
    Duran, C.
    Schweneiberg, J.
    Caicedo, L. A.
    Villegas, J. I.
    Tobon, G. J.
    LUPUS, 2017, 26 (11) : 1157 - 1165
  • [29] Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA
    Obi, Yoshitsugu
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    Rhee, Connie M.
    Reddy, Uttam G.
    Soohoo, Melissa
    Wang, Yaping
    Ravel, Vanessa
    You, Amy S.
    Jing, Jennie
    Sim, John J.
    Nguyen, Danh V.
    Gillen, Daniel L.
    Saran, Rajiv
    Robinson, Bruce
    Kovesdy, Csaba P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 99 - 105
  • [30] Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia
    Patzer, Rachel E.
    Plantinga, Laura C.
    Paul, Sudeshna
    Gander, Jennifer
    Krisher, Jenna
    Sauls, Leighann
    Gibney, Eric M.
    Mulloy, Laura
    Pastan, Stephen O.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (06): : 582 - 594